These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. Kollmeier MA, Stock RG, Cesaretti J, Stone NN. J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274 [Abstract] [Full Text] [Related]
5. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. Walsh PC. J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186 [Abstract] [Full Text] [Related]
9. Laparoscopic radical prostatectomy after transurethral resection of the prostate: surgical and functional outcomes. Menard J, de la Taille A, Hoznek A, Allory Y, Vordos D, Yiou R, Abbou CC, Salomon L. Urology; 2008 Sep; 72(3):593-7. PubMed ID: 18762050 [Abstract] [Full Text] [Related]
10. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer? Merrick GS, Butler WM, Lief JH, Dorsey AT. Tech Urol; 2001 Mar; 7(1):12-9. PubMed ID: 11272667 [Abstract] [Full Text] [Related]
11. Does laser ablation prostatectomy lead to oncological compromise? Biers SM, Oliver HC, King AJ, Adamson AS. BJU Int; 2009 Feb; 103(4):454-7. PubMed ID: 18782304 [Abstract] [Full Text] [Related]
12. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Jones JS, Follis HW, Johnson JR. Prostate Cancer Prostatic Dis; 2009 Feb; 12(1):57-60. PubMed ID: 18379587 [Abstract] [Full Text] [Related]